JP2013505038A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505038A5
JP2013505038A5 JP2012529249A JP2012529249A JP2013505038A5 JP 2013505038 A5 JP2013505038 A5 JP 2013505038A5 JP 2012529249 A JP2012529249 A JP 2012529249A JP 2012529249 A JP2012529249 A JP 2012529249A JP 2013505038 A5 JP2013505038 A5 JP 2013505038A5
Authority
JP
Japan
Prior art keywords
insulin
lobenox
glycoconjugate
anticoagulant
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2012529249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/063516 external-priority patent/WO2011032962A1/en
Publication of JP2013505038A publication Critical patent/JP2013505038A/ja
Publication of JP2013505038A5 publication Critical patent/JP2013505038A5/ja
Abandoned legal-status Critical Current

Links

JP2012529249A 2009-09-18 2010-09-15 薬剤投与デバイス Abandoned JP2013505038A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170720 2009-09-18
EP09170720.8 2009-09-18
PCT/EP2010/063516 WO2011032962A1 (en) 2009-09-18 2010-09-15 Medicament administration device

Publications (2)

Publication Number Publication Date
JP2013505038A JP2013505038A (ja) 2013-02-14
JP2013505038A5 true JP2013505038A5 (enExample) 2013-10-24

Family

ID=41665333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529249A Abandoned JP2013505038A (ja) 2009-09-18 2010-09-15 薬剤投与デバイス

Country Status (6)

Country Link
US (1) US20120266877A1 (enExample)
EP (1) EP2477680B1 (enExample)
JP (1) JP2013505038A (enExample)
CA (1) CA2772583A1 (enExample)
DK (1) DK2477680T3 (enExample)
WO (1) WO2011032962A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2871021A1 (en) * 2012-04-20 2013-10-24 Smiths Medical Asd, Inc. Medication dispensers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313439A (en) 1980-03-24 1982-02-02 Biotek, Inc. Automated, spring-powered medicament infusion system
US4364392A (en) * 1980-12-04 1982-12-21 Wisconsin Alumni Research Foundation Detachable balloon catheter
US4424057A (en) 1982-04-01 1984-01-03 House Hugh A Wet-dry syringe
DK0637223T3 (da) * 1991-05-29 1999-04-26 Origin Medsystems Inc Tilbageholdelsesanordning til endoskopisk kirurgi
US5700245A (en) * 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
AU2001296588B2 (en) * 2000-10-04 2006-06-08 Insulet Corporation Data collection assembly for patient infusion system
US7785277B2 (en) * 2005-06-23 2010-08-31 Celleration, Inc. Removable applicator nozzle for ultrasound wound therapy device
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms

Similar Documents

Publication Publication Date Title
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
WO2011086093A3 (en) Pharmaceutical compositions for oral administration of insulin peptides
MX347504B (es) Formulaciones concentradas de proteina y usos de las mismas.
HUE045348T2 (hu) Fehérje-hatóanyag konjugátumok és eljárás elõállításukra
MX347893B (es) Conjugados de farmaco y anticuerpo humano contra factor de tejido.
LT2013018A (lt) Farmacinė kompozicija, skirta gydyti diabetą ir metabolinius sutrikimus
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
IL249830A0 (en) Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP3192526A3 (en) Exosomes for delivery of biotherapeutics
WO2017091749A8 (en) Shape changing drug delivery devices and methods
HUE044778T2 (hu) Humán RPE sejt gyógyászati készítmények és alkalmazásaik
EP2699252A4 (en) METHOD FOR THE ADMINISTRATIVE ADMINISTRATION OF PTH, PTHRP AND SIMILAR PEPTIDES
BR112015012014A2 (pt) proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb)
EA201290590A1 (ru) Модифицированные туберкулезные антигены
PH12013500108A1 (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EP4338803A3 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
IL219579B (en) Use of fusion proteins for preparation of medicaments for treatment and prophylaxis of diseases of the respiratory tract
EA201491258A1 (ru) Самосшивающие катетеры
EP2880160A4 (en) ISOLATION OF TRAFFIC-REINFORCING MUTANTS OF AN ACTIVE-SPREADING PROTEIN
FR2930249B1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
EP2528939A4 (en) RECOMBINANT PROTEINS FOR USE IN VACCINES, ANTIBODIES TO THESE PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC PROCEDURES THEREWITH
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции
UA109148C2 (uk) Композиції на основі антитіла проти vegfr-3
WO2014165513A3 (en) Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
IL217519A (en) Tazarotene derivatives, pharmaceutical compositions comprising them and use thereof for the manufacture of medicaments for the treatment of skin disorders